Drug and Medication Industry in Russian Federation: Market Research Reports, Statistics and Analysis

Company Report: Drug In Russian Federation For Year 2012

... Increase). The share of product segments in ojsc Veropharm Sales is as follows: group of pharmaceutical products Rx drugs sales amounted to rur 2,142.1 Mln. The rx drugs sales made 67.6% Of total ...

Company Report: Drug And Medication In Russian Federation, India ...

... lansoprazole otc, and was further supported by volume growth in existing key products like ziprasidone, fondaparinux, quetiapine, etc, marginally offset by regular yoy price declines in existing product ...

Company Report: Drug And Medication In The United States, India A ...

Company Report: Drug In Russian Federation For Year 2012

... For the first nine months in 2011. The gross profit ratio of the segments of ojsc Veropharm Is as stated: group of pharmaceutical products In relation to rx drugs it made 73 ...

Company Report: Drug And Medication In Europe For Year 2012

... Used to treat breast cancer in postmenopausal women, letrozole in the form of 2.5 Mg film-coated tablets is applied when immediate operation is inappropriate. This medicine is also efficient in post ...

Company Report: Drug In Russian Federation For Year 2012

... For the first nine months in 2011. The gross profit ratio of the segments of ojsc Veropharm Is as stated: group of pharmaceutical products In relation to rx drugs it made 73 ...

The Russian Drug And Medication Sector : Key Market Figures

... And + hydrochlorothiazide tablets 50mg+12,5mg azithromycin azithromycin tablets 250mg,500mg,125mg codelac neo tablets butamirate tablets 50mg new products the following new products are expected to be released ...

Hormone Sector In Europe

... Diane 35 combined oral contraceptive norethisterone enanthate 200 mg/ml noristerat parenteral progestogen-only contraceptive depo-medroxyprogesterone acetate (dmpa) depo-provera parenteral long ...

Drug And Medication Sector Statistics In Europe